Legislation to tighten controls over the California stem cell agency is scheduled for a hearing April 20 before the California State Senate Health Committee.
The measures are authored by Sen. Deborah Ortiz, D-Sacramento, chair of the Health Committee. Often hearing dates change, so keep in mind that this could be rescheduled. The measures are SB18 and SCA 13, which is a proposed constitutional amendment.
No comments:
Post a Comment